Alamar Biosciences, Inc. · NASDAQ:ALMR
Illumina Innovation Fund II GP, L.L.C. bought 235,294 Alamar Biosciences, Inc. shares (Form 4)
Traded Apr 20, 2026 · Filed Apr 20, 2026
On Apr 20, 2026, Illumina Innovation Fund II GP, L.L.C. (10% owner) bought 235,294 Alamar Biosciences, Inc. shares at US$17.00 for US$4M, leaving 507,076 shares. Filed Apr 20, 2026 (Form 4).
- Bought
- 235,294 shares
- Price
- US$17.00
- Value
- US$4M
- Holding after
- 507,076 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Class B Common Stock | Conversion | 4,588,364 | 4,588,364 | Indirect | |
| Apr 20, 2026 | Class B Common Stock | Conversion | 922,152 | 5,510,516 | Indirect | |
| Apr 20, 2026 | Common Stock | Other | 5,510,516 | 5,510,516 | Indirect | |
| Apr 20, 2026 | Common Stock | Conversion | 346,020 | 5,856,536 | Indirect | |
| Apr 20, 2026 | Common Stock | Conversion | 271,782 | 271,782 | Indirect | |
| Apr 20, 2026 | Common Stock | Buy | 235,294 | US$17.00 | 507,076 | Indirect |
Source
Related
- Alamar Biosciences, Inc.
- Illumina Innovation Fund II GP, L.L.C.
- Alamar Biosciences, Inc. shareholders
- Form 4 · Qiming Corporate GP VI, Ltd. · Oct 23, 2026
- Form 4 · Qiming Corporate GP VI, Ltd. · Oct 21, 2026
- Schedule 13G · Yuling Luo · Aug 13, 2026
- Schedule 13G · Qiming Corporate GP VI, Ltd. · Aug 11, 2026
- Schedule 13D/A · Sands Capital Life Sciences Pulse Fund II, L.P. · Jul 7, 2026